Hepatitis C in patients with end stage renal disease. I. Prevalence;Hepatitis viral C en pacientes con insuficiencia renal crónica terminal. I Prevalencia

Revista de Investigacion Clinica

Volumn 52, Issue 3, 2000, Pages 246-254

  González Michaca, Luis ^a,b   Mercado, Adriana ^a   Gamba, Gerardo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Medicina del Dolor y Paliativa   (Mexico)

Author keywords

Dialysis; End stage renal disease; Hepatitis C; Prevalence

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PREVALENCE; RENAL REPLACEMENT THERAPY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS;

EID: 0034183015     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Seaworth WW, Garrett LE, Hamilton JD. Non-A, non-B hepatitis and chronic dialysis: Another dilemma. Am J Nephrol 1984; 4: 235-9.
2. Shusterman N, Singer I. Infectious hepatitis in dialysis patients. Am J Kidney Dis 1987; 9: 447-55.
3. Gailbraith RM, Dienstag JL, Purcell RH. Non-A, non-B hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet 1979; 1: 951-3.
4. Mazzoni A, Innocenti M, Consaga M. Retrospective study on the prevalence of B and non-A, non-B hepatitis in a dialysis unit: 17-year follow-up. Nehpron 1992; 61: 316-7.
5. Jeffers LJ, Perez GO, DeMedina M. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1980; 38: 320-2.
6. Lin HH, Huang CC, Sheen IS, Lin DY. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol. 1991; 11: 192-4.
7. Almorth G, Kormo B, Hed J. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients. Nephron 1991; 59: 232-5.
8. Hayashi J, Nakashima K, Kajiyama W, Noguchi A, Morofuji M, Kashiwagi S et al. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991; 134: 651-7.
9. Simon N, Courouce AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialysed patients. Kidney Int 1994; 46: 504-11.
10. Rivanera D, Lilli D, Lorino G, Pirozzi V, Cannulla V, Mancini C et al. Detection of antibodies to hepatitis C virus in dialysis patients. Eur J Epidemiol 1993; 9: 55-8.
11. DaPorto A, Adami A, Susanna F. Hepatitis C virus in dialysis units: A multicenter study. Nephron 1992; 61: 309-10.
12. Conway M, Castterall AP, Brown EA. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant. 1992; 7: 1226-9.
13. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis. 1993; 22: 568-73.
14. Fabrizi F, Raffaele L, Bacchini G, Guarnori I, Pontoriero G, Locatelli F, et al. Antibodies to hepatitis C virus and transaminase concentration in chronic haemodialysis patients: a study with second-generation routes other than transfusion may occur and diagnosis may be delayed in this group of patients probably due to a poor immunological response. Nephrol Dial Transplant 1993; 8: 744-7.
15. Vandelli L, DePalma M, Vecchi C, Lusvarghi E. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis. Nephron 1992; 61: 260-2.
16. Tokars J, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA. National surveillance of hemodialysis associated diseases in the United States. 1992. ASAIO J 1994; 40: 1020-31.
17. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981-99.
18. Spanish Multicentre Study Group. Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol Dial Transplant 1995; 10: 78-80.
19. Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies on patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31-3.
20. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38: 44-8.
21. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Erba G, Locatelli F et al. IgM antibody response to hepatitis C virus in end-stage-renal disease. Nephrol Dial Transplant 1996; 11: 314-8.
22. Alberú J, Lisker-Melman M, González F, Vargas-Vorácková F, Bordes-Aznar J, Correa-Rotter R et al. Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant at waiting list in Mexico. Transplantation Proc 1996; 28: 3298-300.
23. Sambrook J, Fritsch EF, Maniatis T. 1989. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular cloning. A laboratory manual. Sambrook J, Fritsch EF, and Maniatis T. editors. Cold Spring Harbor Laboratory Press, New York. pp. 7.3-7.6.
24. Cendoroglo NM, Manzano SI, Canziani ME, Silva AE, Cirenza LF, Sesso RC, Ajzen H, Daribe SA. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis units. Artif Organs 1995; 19: 251-5.
25. Barril G, Traver JA. Prevalence of hepatitis C virus in dialysis patients in Spain. Nephrol Dial Transplant 1995; 10(Suppl 6): 78-80.
26. Gilli P, Soffritti S, DePaoli-Vitali E, Bedani PL. Prevention of hepatitis C virus in dialysis units. Nephron 1995; 70: 301-6.
27. Lee GS, Roy DK, Fan FY, Thanaletchumi K, Woo KT. Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors. Perit Dial Int 1996; 16: S424-8.
28. Natov SN, Lau JY, Bouthot BA, Murthy BV, Ruthazer R, Pereira BJ et al. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 1998; 31: 920-7.
29. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gitnick G, et al. Quantitative assessment of HCV load in chronic hemodialysis patients: across-sectional survey. Nephron 1998; 80: 428-33.
30. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreno V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470-3.
31. Castelnovo C, Samptetro M, De Veechi A, Corbetta N, Lunghi G, Ponticelli C et al. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 978-80.
32. Gladziwa U, Schlipkoter U, Lorbeer B, Cholmakow K, Roggendorf M, Sieberth HG. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis - a multicenter study. Clin Nephrol 1993; 40: 46-52.
33. Kruatzig S, Tillmann H, Wrenger E, Manns M, Koch KM, Brunkhorst R. Hepatitis C virus (HCV) in peritoneal dialysis patients. Clin Nephrol 1994; 41: 120.
34. Valtuille R, Fernandez JL, Berridi J, Moretto H, del Pino N, Lef L et al. Evidence of hepatitis C virus passage across dialysis membrane. Nephron 1998; 80: 194-6.